Receptor binding and predictive toxicology. Eurofins panlabs INC. N01DA-23-8937. POP september 26, 2023 to september 25, 2028.

Active Indefinite Delivery Contract Awarded Last action

Contract number
75N95023D00021
Awardee
Awarding agency
Task orders
5 $960,114 obligated

Award facts

Opportunity
Combined order value
$960,114 Current and potential, with all options
Last date to order 62% complete
IDV ceiling 19% used
$5,000,000.00
Maximum order
$5,000,000.00
Award type
Single award
Who can order
Only the awarding agency
Set-aside
Total Small Business
Competition
Full and Open Competition after exclusion of sources · 1 offer Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Legislative mandates

Award details come from SAM.gov/FPDS.

About this IDV

The National Institute on Drug Abuse (NIDA) awarded a $5 million single-award Indefinite Delivery Vehicle (IDV) contract to Eurofins Discovery Services North America, LLC (UEI: HF4LCAU68M93) on September 26, 2023, with performance extending through September 25, 2028. The IDV was designated as a Total Small Business set-aside despite the vendor's later task orders utilizing no small business set-aside designations. Under this vehicle, Eurofins provides receptor binding studies and predictive toxicology services to support NIDA's drug abuse and addiction research programs. The contractor, a foreign-owned contract research organization headquartered in St. Charles, Missouri, performs work primarily at its facility in St. Peters, Missouri, and possesses specialized expertise in receptor profile screening, safety pharmacology, analytical chemistry, and non-clinical laboratory support methodologies required for pharmaceutical and drug abuse research initiatives.

Four delivery orders have been executed under this IDV to date, totaling approximately $825,667 in awarded value. These include a Cost Plus Fixed Fee task order (September 26, 2023–September 25, 2024, $142,193) for receptor binding and predictive toxicology services; a Firm Fixed Price delivery order (April 12, 2024–October 31, 2025, $300,609) for receptor profile screening and toxicology assays; a Firm Fixed Price delivery order (June 25, 2025–June 24, 2026, $132,771.58) for receptor profile screening services; and a Firm Fixed Price delivery order (September 21, 2025–September 20, 2026, $249,093.62) for receptor profile screening services. All deliveries are performed at the St. Peters, Missouri location. These task orders align with NIDA's mission to advance understanding of drug abuse mechanisms through rigorous scientific research and testing of candidate compounds across multiple biological receptor targets.

Task orders

Transactions

Action Obligated Date
Other Administrative Action P00003 $0
Other Administrative Action P00002 $0
Change Order P00001 $0
Original award $0

Quick answers

Who was awarded contract 75N95023D00021?

75N95023D00021 was awarded to Eurofins Discovery Services North America, LLC by National Institute on Drug Abuse (National Institutes of Health) on September 26, 2023.

How much is contract 75N95023D00021 worth?

Orders under 75N95023D00021 have obligated $960,114. 75N95023D00021's own ceiling is $5,000,000. A single order can be worth up to $5,000,000.

How many orders have been placed under contract 75N95023D00021?

5 orders have been placed under 75N95023D00021, the latest on September 1, 2026.

Who can order from contract 75N95023D00021?

75N95023D00021 is a single award indefinite delivery contract. Only the awarding agency can place orders on it.

Was contract 75N95023D00021 competed?

The extent of competition for 75N95023D00021 was full and open competition after exclusion of sources. The government received 1 offer. It was set aside: Total Small Business.

On GovTribe

See this IDV's full record

  • Every order and transaction
  • The awardee's other awards and teaming partners
  • Similar IDVs and recompete opportunities
  • Ask GovTribe AI about this IDV